Indian pharma companies escape Trump’s reciprocal tariffs, for now
Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...
Medical Marketing & Media4h
Trump’s sweeping new tariffs inject more uncertainty into pharma industry
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Trump's Reciprocal Tariffs On India Exempt Pharma, Easing Mark Cuban's Price Hike Concerns
Billionaire entrepreneur and co-founder of Cost Plus Drugs, Mark Cuban's apprehensions of having to raise medicine prices in response to Trump's reciprocal tariffs on India is put to rest.